Skip to main content
. Author manuscript; available in PMC: 2018 Jan 5.
Published in final edited form as: Vaccine. 2016 Dec 3;35(2):329–336. doi: 10.1016/j.vaccine.2016.11.059

Figure 2. High dose vaccine recipients had a greater increase in activated pTfh cells.

Figure 2

The frequency of pTfh cells with individual activation markers (A–C) or combinations of activation markers (D–F) for standard dose (SD) and high dose (HD) vaccine recipients before (day 0) and after (day 7) vaccination.

HHS Vulnerability Disclosure